133 related articles for article (PubMed ID: 3022711)
1. Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
Biken J; 1986 Mar; 29(1):7-10. PubMed ID: 3022711
[TBL] [Abstract][Full Text] [Related]
2. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
[TBL] [Abstract][Full Text] [Related]
3. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
[TBL] [Abstract][Full Text] [Related]
7. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.
Roberts GB; Fyfe JA; Gaillard RK; Short SA
J Virol; 1991 Dec; 65(12):6407-13. PubMed ID: 1658351
[TBL] [Abstract][Full Text] [Related]
8. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
9. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
10. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
Shigeta S; Yokota T
Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
[No Abstract] [Full Text] [Related]
13. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
Morfin F; Thouvenot D; De Turenne-Tessier M; Lina B; Aymard M; Ooka T
Antimicrob Agents Chemother; 1999 Oct; 43(10):2412-6. PubMed ID: 10508017
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
15. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
[TBL] [Abstract][Full Text] [Related]
16. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
Biron KK; Fyfe JA; Noblin JE; Elion GB
Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.
Talarico CL; Phelps WC; Biron KK
J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452
[TBL] [Abstract][Full Text] [Related]
18. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.
Ida M; Kageyama S; Sato H; Kamiyama T; Yamamura J; Kurokawa M; Morohashi M; Shiraki K
Antiviral Res; 1999 Jan; 40(3):155-66. PubMed ID: 10027650
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
Morfin F; Thouvenot D; Aymard M; Souillet G
J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
